CTSHCognizant

$70.55+9.5% 1Y

The financials

Cognizant by the numbers

Cognizant (CTSH) reported revenue of $5.48B in Q2 2026 (quarter ended Jun 30, 2026), up 4.5% from the same quarter a year earlier. That came with a gross margin of 33% and net income of $636M (12% of revenue). For the full year FY2025, revenue was $21.1B (+7.0% year on year) and net income $2.23B. Its largest segment in Q2 2026 was Health Sciences at $1.31B, 32% of the disclosed total, just ahead of Financial Services at 31%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.

Cognizant income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$5.48B$5.25B+4.5%
Gross profit$1.83B$1.77B+3.6%
Operating income$874M$817M+7.0%
Net income$636M$645M−1.4%
Diluted EPS$1.36$1.31+3.8%
Revenue by segment, Q2 2026, as reported to the SEC
OperatingRevenueShare
Health Sciences$1.31B32%
Financial Services$1.26B31%
Productsand Resources$918M22%
Communications Media And Technology$639M15%

Business segments

Revenue split by operating segment, from SEC XBRL filings.

Latest period: Jun 2026Total $4.13B (+1.9%)
Financial Services grew +15% year on yearProducts and Resources 0.00% year on year
  • Health Sciences$1.31Bquarter on quarter -0.31%year on year +0.69%
  • Financial Services$1.26Bquarter on quarter +7.4%year on year +15%
  • Products and Resources$918.0Mquarter on quarter +0.22%year on year 0.00%
  • Communications Media And Technology$639.0Mquarter on quarter -1.5%year on year +6.5%
Segment sum = 75% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed Jul 29, 2026, SEC EDGAR